Concepedia

Mary E. Klein

ME

Statistics

Publications

5

Citations

341

H-Index

5

Active since

2013

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Kettering University

Mary E. Klein is an author at Memorial Sloan Kettering Cancer Center specializing in molecular oncology, cancer pharmacology, and cancer cell senescence.

ORCID

Publications per year

2013–2023

5

Publications

5

MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition

Marta Kovatcheva, David D. Liu, Mark A. Dickson et al. · Oncotarget · 2015 · 143 citations · Full text

, , +15

ATRX is a regulator of therapy induced senescence in human cells

Marta Kovatcheva, Will Liao, Mary E. Klein et al. · Nature Communications · 2017 · 91 citations · Full text

, , +14

PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence

Mary E. Klein, Mark A. Dickson, Cristina R. Antonescu et al. · Oncogene · 2018 · 53 citations · Full text

, , +16

Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

Caroline E. Gleason, Mark A. Dickson, Mary E. Klein et al. · Clinical Cancer Research · 2023 · 34 citations · Full text

, , +17

A model of sensitivity and resistance to histone deacetylase inhibitors in diffuse large B cell lymphoma

Ana A. Tula-Sanchez, Aaron Havas, Peter J Alonge et al. · Cancer Biology & Therapy · 2013 · 20 citations · Full text

, , +13

1–5 of 5